Article
Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 [corrected] with type 2 diabetes.
Diabetes - 1 Mar 2006
Sun Maria W, Lee Jennifer Y, de Bakker Paul I W, Burtt Noël P, Almgren Peter, Råstam Lennart, Tuomi Tiinamaija, Gaudet Daniel, Daly Mark J, Hirschhorn Joel N, Altshuler David, Groop Leif, Florez Jose C
Abstract excerpt
AMP-activated protein kinase (AMPK) is a key molecular regulator of cellular metabolism, and its activity is induced by both metformin and thiazolidinedione antidiabetic medications. It has therefore been proposed both as a putative agent in the pathophysiology of type 2 diabetes and as a valid target for therapeutic intervention. Thus, the genes that encode the various AMPK subunits are intriguing candidates for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
